Biotech · Private company
Rophibio, Inc.
Track this companyFree. Adds Rophibio, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- Eylea® Solution for intravitreal injectionPhase 3 · Neovascular Age-related Macular Degeneration (nAMD)ClinicalTrials.gov · fetched Nov 12, 2026
- RBS-001 Solution for intravitreal injectionPhase 3 · Neovascular Age-related Macular Degeneration (nAMD)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- A Phase 3 Clinical Trial to Compare RBS-001 to Eylea® in Subjects With Neovascular Age-Related Macular DegenerationPHASE3 · NOT_YET_RECRUITING · started Jul 1, 2025ClinicalTrials.gov NCT06470373 · fetched Nov 12, 2026